Core Framework & Diagram How Do Cancer Cells Evade the Immune System? 2
July 6, 2026Core Framework & Diagram What Is Tumor Microenvironment?
July 6, 2026
1 minuete Read
What Is Tumor Microenvironment?
Tumors aren't isolated cell masses — they're ecosystems that actively shape their surrounding world
By the Editors 1-min read
Have you wondered why the same immunotherapy produces stunning results in one patient and has absolutely no effect in another? Much of the answer hides in the 'tumor microenvironment.'
Tumors aren't isolated cell clusters. Around them is a complex ecosystem: blood vessels, fibroblasts, immune cells, extracellular matrix, various signaling molecules. Tumors actively shape this environment, turning it into a 'restricted zone' favorable for their own survival and growth but unfavorable for immune cell activity.
Understanding the tumor microenvironment is the key to explaining why immunotherapy sometimes works and sometimes doesn't — and to designing next-generation treatment strategies.
KEY TAKEAWAYS
01
Tumors aren't isolated cell masses but actively shaped ecosystems — the tumor microenvironment (TME) is the immune restricted zone tumors build.
02
'Hot tumors' (with T cell infiltration) respond well to checkpoint inhibitors; 'cold tumors' (without T cell infiltration) need T cells recruited first before talking about unlocking them. This distinction determines treatment strategy.
03
Low oxygen + acidity + metabolic competition: three physical-chemical environmental factors collectively damaging immune cell activity — the environmental reason why many immunotherapies have limited efficacy in solid tumors.
04
CAFs (cancer-associated fibroblasts) form physical barriers, blocking immune cells outside the tumor — an important obstacle to solid tumor immunotherapy and a new research target.
05
Adenosine (via CD73/CD39) is a newly discovered important immunosuppressive signal, forming an 'anesthetic field' around tumors. Multiple drugs targeting the adenosine pathway are in clinical trials.
06
Next-generation cancer immunotherapy direction: 'activate immunity + remodel TME' simultaneously. Relying only on activating the immune system is insufficient to break through TME's defensive system.
Read Next
